acetoacetic acid has been researched along with Acute Confusional Senile Dementia in 5 studies
acetoacetic acid : A 3-oxo monocarboxylic acid that is butyric acid bearing a 3-oxo substituent.
Excerpt | Relevance | Reference |
---|---|---|
"Sporadic Alzheimer's disease (AD) is responsible for 60%-80% of dementia cases, and the most opportune time for preventive intervention is in the earliest stage of its preclinical phase." | 1.43 | Ketones block amyloid entry and improve cognition in an Alzheimer's model. ( Dharshaun, T; Eisenberg, D; Gao, M; Han, P; Maalouf, M; Reiman, EM; Ryan, C; Schweizer, FE; Shi, J; Whitelegge, J; Wu, J; Yin, JX; Zhao, M, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akram, M | 1 |
Castellano, CA | 2 |
Nugent, S | 1 |
Paquet, N | 2 |
Tremblay, S | 2 |
Bocti, C | 2 |
Lacombe, G | 2 |
Imbeault, H | 2 |
Turcotte, É | 1 |
Fulop, T | 2 |
Cunnane, SC | 2 |
Thomas, SC | 1 |
Alhasawi, A | 1 |
Appanna, VP | 1 |
Auger, C | 1 |
Appanna, VD | 1 |
Yin, JX | 1 |
Maalouf, M | 1 |
Han, P | 1 |
Zhao, M | 1 |
Gao, M | 1 |
Dharshaun, T | 1 |
Ryan, C | 1 |
Whitelegge, J | 1 |
Wu, J | 1 |
Eisenberg, D | 1 |
Reiman, EM | 1 |
Schweizer, FE | 1 |
Shi, J | 1 |
Dionne, IJ | 1 |
Langlois, F | 1 |
Croteau, E | 1 |
Fortier, M | 1 |
Matte, JJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Optimisation of Acute Medium Chain Triglycerides Intake Characteristics on Different Plasma Metabolites in Young and Older Participants[NCT03830268] | 20 participants (Actual) | Interventional | 2017-06-02 | Completed | |||
Effect of a Ketogenic Supplement on Brain Energy Metabolism Measured by Neuroimaging in Mild Cognitive Impairment[NCT02551419] | 82 participants (Actual) | Interventional | 2015-06-30 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for acetoacetic acid and Acute Confusional Senile Dementia
Article | Year |
---|---|
A focused review of the role of ketone bodies in health and disease.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Acetone; Alzheimer Disease; Blood Glucose; Diabetic Ketoacidos | 2013 |
Brain metabolism and Alzheimer's disease: the prospect of a metabolite-based therapy.
Topics: Acetoacetates; Adenosine Triphosphate; Aluminum; Alzheimer Disease; Astrocytes; Brain; Carnitine; Hu | 2015 |
1 trial available for acetoacetic acid and Acute Confusional Senile Dementia
Article | Year |
---|---|
A 3-Month Aerobic Training Program Improves Brain Energy Metabolism in Mild Alzheimer's Disease: Preliminary Results from a Neuroimaging Study.
Topics: Acetoacetates; Aged; Alzheimer Disease; Brain; Cognition; Exercise Therapy; Female; Glucose; Humans; | 2017 |
2 other studies available for acetoacetic acid and Acute Confusional Senile Dementia
Article | Year |
---|---|
Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Topics: Acetoacetates; Aged; Alzheimer Disease; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorode | 2015 |
Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Topics: Acetoacetates; Aged; Alzheimer Disease; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorode | 2015 |
Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Topics: Acetoacetates; Aged; Alzheimer Disease; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorode | 2015 |
Lower brain 18F-fluorodeoxyglucose uptake but normal 11C-acetoacetate metabolism in mild Alzheimer's disease dementia.
Topics: Acetoacetates; Aged; Alzheimer Disease; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorode | 2015 |
Ketones block amyloid entry and improve cognition in an Alzheimer's model.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition; | 2016 |